Search clinical trials for: Placebo to Ramipril

Total 60601 results

Novartis Pharmaceuticals

Completed

Effects of Aliskiren, Ramipril, and the Combination on Levels of Angiotensin II in Patients With Decompensated Systolic Heart Failure (ESCAPE-SHF)

Heart Failure

Russian Federation, Germany, Poland
Novartis

Completed

A Study Evaluating the Gastrointestinal (GI) Safety and Tolerability of Aliskiren Compared to Ramipril in Essential Hypertension

Hypertension

United States, Argentina, Colombia, France, Germany, India, Spain
Novartis

Completed

Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients (ALIAS)

Essential Hypertension

France
Institut fuer anwendungsorientierte Forschung und...
German Federal Ministry of Education and Research; University Medical Center...

Completed

Efficacy and Safety Study to Delay Renal Failure in Children With Alport Syndrome

Renal Insufficiency, Chronic

Germany
Pfizer

Terminated

A Study of the Effectiveness and Safety of Ramipril in the Treatment of Hypertension in Children and Adolescents

Hypertension

United States, Argentina, Colombia, India, Chile, Poland, South Africa, Turkey, Ukraine
Medical University of Vienna

Completed

Gene Expression Profiling in Skeletal Muscle of Healthy Subjects Treated With Ramipril

Healthy

Austria
Stanford University
Cedars-Sinai Medical Center; VA Palo Alto Health Care System

Completed

Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy

Cardiac Allograft Vasculopathy

United States
University of California, San Diego
Pfizer

Completed

Ramipril for the Treatment of COVID-19 (RAMIC)

COVID-19

United States
Bristol-Myers Squibb
Sanofi

Completed

Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria

Albuminuria

United States, Spain, Netherlands, Canada, Italy, Mexico, Israel, Australia, Russian Federation, United Kingdom, France, Germany, Latvia, Lithuania
Bispebjerg Hospital

Completed

Effect of ACE-Inhibition on Microvascular Function in Women With Assessed Microvascular Dysfunction

Microvascular Angina

Denmark
Bayside Health

Completed

Angiotensin Converting Enzyme (ACE) Inhibition and Peripheral Arterial Disease

Peripheral Arterial Disease

Australia
Novartis Pharmaceuticals

Terminated

To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy (ARIA)

Non-diabetic Nephropathy

Netherlands
University of Michigan
Novartis Pharmaceuticals

Withdrawn

The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome (SAAVE)

Hypertension | Metabolic Syndrome

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fed Conditions

Healthy

United States
Boehringer Ingelheim

Completed

Bioequivalence of Telmisartan/g Ramipril Fixed Dose Combination Compared With the Monocomponents Telmisartan and Ramipril (Two Different Formulations) Given Concomitantly to Healthy Male and Female Volunteers

Healthy
Boehringer Ingelheim

Completed

Bioequivalence of Telmisartan / Ramipril Fixed Dose Combination Compared With the Monocomponents Given Concomitantly to Healthy Male and Female Volunteers

Healthy
Sandoz

Completed

To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions

Hypertension
Indonesia University

Recruiting

The Effect of Ramipril in Suppressing ST2 Expression in Rheumatic Mitral Stenosis Patients

Rheumatic Heart Disease | ACE Inhibitor | Mitral Stenosis | Rheumatic Mitral Stenosis | Fibrosis; Heart

Indonesia
Gulhane School of Medicine

Completed

The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria

Diabetes | Proteinuria | Renin Angiotensin System

Turkey
Sandoz

Completed

To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Non-Fasting Conditions

Hypertension
Actavis Inc.

Completed

A Relative Bioavailability Study of Ramipril 10 mg Capsules Administered Orally as a Sprinkle on Applesauce

Healthy

United States
Sanofi

Completed

An Open-label, Non-comparative Study to Document the Tolerability to Ramipril in Patients With at Least One High Risk for Developing a Major Cardiovascular Event (HOPETips)

Coronary Artery Disease

Indonesia
Actavis Inc.

Completed

A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions

Healthy

United States
Boehringer Ingelheim
Eli Lilly and Company

Completed

Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN Study

Obesity | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Ramipril 10 mg Capsules Under Fed Conditions

Healthy

India
Institut de Recherches Cliniques de Montreal

Terminated

Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes

Hypertension | Type 2 Diabetes | Albuminuria

Canada
Pfizer
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Treatment of Pediatric Hypertension With Altace Trial

Hypertension

United States
Gulhane School of Medicine

Completed

Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria

Diabetic Nephropathy | Proteinuria | Chronic Kidney Disease

Turkey
Noema Pharma AG

Recruiting

Basimglurant in Children, Adolescents, and Young Adults With TSC

Tuberous Sclerosis Complex

United States, India, Israel, Turkey, Italy, Poland, Spain, United Kingdom
Alyatec

Completed

Evaluation of the Nasal and Conjunctival Response in Subjects Allergic to Birch Pollen in the ALYATEC Environmental Exposure Chamber

Allergic Rhinitis | Rhinoconjunctivitis | Allergy to Pollen

France
HaEmek Medical Center, Israel

Recruiting

Explorative Study for Treating Persistent Developmental Stuttering With Ramipril

Persistent Developmental Stuttering

Israel
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Ramipril 10 mg Capsules Under Fasting Conditions

Healthy

India
Pfizer

Completed

Study Evaluating The Effect Of Ramipril On Urinary Protein Excretion In Renal Transplant Patients Converted To Sirolimus

Kidney Transplant

United States, Brazil, Australia, South Africa, Germany, Hungary, Poland, Israel, Canada, Austria, Argentina, Mexico
Novartis Pharmaceuticals

Recruiting

Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa

Hidradenitis Suppurativa

Spain, France, United States, Austria, Germany, Hungary, Belgium, Iceland, Netherlands, Denmark, Czechia
CoMentis
Alpharmagen, Inc.

Suspended

Safety, Tolerability, and Pharmacokinetics of APN1125 in Subjects With Schizophrenia

Schizophrenia

United States
Vanderbilt University
National Institutes of Health (NIH)

Completed

Renin Angiotensin Aldosterone System (RAAS) and Fibrinolysis in Humans: ACEi and PE5i

Metabolic Syndrome
Vanderbilt University
National Heart, Lung, and Blood Institute (NHLBI); University of Washington

Terminated

Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3

Endothelial Dysfunction | Oxidative Stress

United States
Kallyope Inc.

Completed

A Study to Evaluate the Safety, Tolerability, and Weight Loss Efficacy of K-757 Alone and in Combination With K-833

Obesity

United States
ReveraGen BioPharma, Inc.
Santhera Pharmaceuticals

Recruiting

A Study to Assess Vamorolone in Becker Muscular Dystrophy (BMD)

Becker Muscular Dystrophy

United States, Italy
Novartis Pharmaceuticals

Active, not recruiting

Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD (Lp(a)HORIZON)

Cardiovascular Disease and Lipoprotein(a)

United States, China, Germany, South Africa, Italy, Spain, Belgium, Czechia, Hungary, Japan, Taiwan, Netherlands, Australia, Austria, Canada, France, Israel, Switzerland, United Kingdom, Korea, Republic of, Argentina, Denmark, Greece, Romani... and more
Shanghai Pharmaceuticals Holding Co., Ltd

Completed

The Tolerability and Pharmacokinetics of Multiple Doses of SPH3127 in Chinese Healthy People

Hypertension

China
AstraZeneca

Not yet recruiting

A Randomised, Double-blind, Parallel Group, Placebo Controlled, 4-Week, Phase II Study to Evaluate the Effect of AZD4604 on Airway Inflammation and Biomarkers in Adults With Asthma (ARTEMISIA)

Asthma

Canada, Denmark, Germany, Spain, United Kingdom
Bayer

Not yet recruiting

A Study to Learn About the Safety of BAY3283142 in People With Mild to Moderate High Blood Pressure

Chronic Kidney Disease | Arterial Hypertension | Non-proliferative Diabetic Retinopathy

Germany
KalVista Pharmaceuticals, Ltd.

Completed

A Single and Multiple Doses Safety, Tolerability, Pharmacokinetics and Food Effect Study of KVD824 in Healthy Volunteers

Hereditary Angioedema

United Kingdom
Novartis Pharmaceuticals

Terminated

Study on Safety, Tolerability and Prelimenary Efficacy of LNA043 in Patients Undergoing Autologous Chondrocyte Implantation (ACI)

Knee Cartilage Lesion

Austria
AstraZeneca

Completed

To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of Inhaled AZD8683

Healthy

United Kingdom
Bayer

Recruiting

A Study to Learn More About How Well BAY3018250 Works and How Safe it is for People With Proximal Deep Vein Thrombosis (SIRIUS)

Thrombolysis | Symptomatic Proximal Deep Vein Thrombosis

Belgium, France, Italy, Netherlands, Canada, Germany, Czechia
Novartis Pharmaceuticals

Completed

Study to Assess the Efficacy and Safety of CJM112 in Patients With Inadequately Controlled Severe Asthma

Asthma

United States, Belgium, Germany, Israel, Argentina, France, Denmark, Slovakia
KalVista Pharmaceuticals, Ltd.

Completed

A Single Dose Safety, Tolerability, Pharmacokinetic and Food Effect Study of KVD900 in Healthy Volunteers

Hereditary Angioedema

United Kingdom
Novartis Pharmaceuticals

Terminated

Efficacy, Safety, Tolerability and Pharmacokinetics (PK) of Nilotinib (AMN107) in Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial Hypertension

Switzerland, United States, Germany, Singapore, Korea, Republic of, Canada

3

Subscribe